Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL1464303 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTP53TDP1 | |
| Ether SCHEMBL3439245 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTP53TDP1 | |
| Ether SCHEMBL5128631 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTP53TDP1 | |
| Ether SCHEMBL317310 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTP53TDP1 | |
| Ether SCHEMBL9258257 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTP53TDP1 | |
| Ether SCHEMBL9333712 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTP53TDP1 | |
| Ether SCHEMBL1331 | 1.00 | — | — | |
| Ether SCHEMBL9567021 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTP53TDP1 | |
| Ether SCHEMBL9494752 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTP53TDP1 | |
| Ether SCHEMBL1970047 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRTP53TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8093429-B2 | Fluoroamine having perfluoroalkyl group, process for producing the same, method of fluorination therewith, and method of recovering amide having perfluoroalkyl group | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2012-01-10 | — | — | US | disclosed |
| US-20090198086-A1 | FLUOROAMINE HAVING PERFLUOROALKYL GROUP, PROCESS FOR PRODUCING THE SAME, METHOD OF FLUORINATION THEREWITH, AND METHOD OF RECOVERING AMIDE HAVING PERFLUOROALKYL GROUP | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2009-08-06 | — | — | US | disclosed |
| EP-2022776-A1 | FLUOROAMINE HAVING PERFLUOROALKYL GROUP, PROCESS FOR PRODUCING THE SAME, METHOD OF FLUORINATION THEREWITH, AND METHOD OF RECOVERING AMIDE HAVING PERFLUOROALKYL GROUP | National University Corporation Hokkaido University (JP) | 2009-02-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090198086-A1 | FLUOROAMINE HAVING PERFLUOROALKYL GROUP, PROCESS FOR PRODUCING THE SAME, METHOD OF FLUORINATION THEREWITH, AND METHOD OF RECOVERING AMIDE HAVING PERFLUOROALKYL GROUP | AFF2, AFF1, PFAS | ALDH1A1 685/4885TSHR 15/4885TP53 1935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.